Pediatric Hematology/Oncology (AREKEN) Osaka Univ Grad School Med

We are treating children with cancer and hematological disorder at Osaka University Hospital, Japan.
Contact us at areken@ped.med.osaka-u.ac.jp

Sunday, September 03, 2006

Morning Seminar August 29, 2006

Bone Marrow Transplant. 2006 May;37(10):961-5.
  • Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist.
    • Funke VA, de Medeiros CR, Setubal DC, Ruiz J, Bitencourt MA, Bonfim CM, Neto JZ, Pasquini R.

    posted by hohtaped @ 9:15 AM